A comparison of cytokine production in 2-dimensional and 3-dimensional cultures of bone marrow stromal cells of muliple myeloma patients in response to RPMI8226 myeloma cells

Folia Histochemica et Cytobiologica

Volumn 47, Issue 1, 2009, Pages 69-74

  Zdzisińska, Barbara ^a   Roliński, Jacek ^b   Piersiak, Tomasz ^a   Kandefer Szerszeń, Martyna ^a  

^a MARIA CURIE SK ODOWSKA UNIVERSITY   (Poland)

^b MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

3 dimensional; Bone marrow stromal cells; Cytokines; Multiple myeloma

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 11; INTERLEUKIN 6 RECEPTOR; SCATTER FACTOR;

ADULT; AGED; ARTICLE; BONE MARROW CELL; CELL INTERACTION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CULTURE MEDIUM; CULTURE TECHNIQUE; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; MULTIPLE MYELOMA; MYELOMA CELL; STROMA CELL;

AGED; AGED, 80 AND OVER; BONE MARROW CELLS; CELL CULTURE TECHNIQUES; CYTOKINES; FEMALE; HUMANS; MALE; MICROSCOPY, CONFOCAL; MIDDLE AGED; MULTIPLE MYELOMA; STROMAL CELLS; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 66449103807     PISSN: 02398508     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10042-009-0015-1     Document Type: Article

References (21)

1. Arnulf B, Lecourt S, Soulier J, Ternaux B, Lacassagne MN, Crinquette A, Dessoly J, Sciaini AK, Berbunan M, Chomienne C, Fermand JP, Marolleau JP, and Larghero J. Phenotypic and functional characterization of bone marrow mesenchymal stem cells derived from patients with multiple myeloma. Leukemia. 2007;21:158-163.
2. Calabrio A, Oken MM, Hascal VC, and Masellis AM. Characterization of hyaluronian synthetase expression and hyaluronian synthesis in bone marrow mesenchymal progenitor cells: predominant expression of HAS1 mRNA and up-regulated hyaluronian synthesis in bone marrow cells derived multiple myeloma patients. Blood. 2002;100:2578-2585.
3. Caligaris-Cappio F, Bergui L, Gregoretti MG, Gaidano G, Gaboli M, Schena M, Zallone AZ and Marchisio PC. Role of bone marrow stromal cells in the growth of human multiple myeloma. Blood. 1991;77:2688-2693.
4. Corre J, Mahtouk K, Attal M, Gadelorge M, Huynh A, Fleury-Cappellesco S, Danho C, Laharague P, Klein B, Reme T and Bourin P. Bone marrow mesenchymal cells are abnormal in multiple myeloma. Leukemia. 2007;21:1079-1088.
5. Cui ZF, Xu X, Trainor N, Triffitt JT, Urban JP, Tirlapur UK. Application of multiple parallel perfused microbioreactors and three-dimensional stem cell culture for toxicity testing. Toxicol In vitro. 2007;21:1318-1324.
6. Durie BG, Salmon SE. A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment and survival. Cancer. 1975;36:842-845.
7. Ghosh S, Rosenthal R, Zjac P, Weber WP, Oertli D, Heberer M, Martin I, Spagnoli GC, Reschner A. Culture of melanoma cells in 3-dimensional architectures results in impaired immunorecognition by cytotoxic T lymphocytes specific for Malan-A/Mart-1 tumor- associated antigen. Ann Surg. 2005;242:851-858.
8. Gregoretti MG, Gottardi D, Ghia P, Bergui L, Merico F and Marchisio PC. Characterization of bone marrow stromal cells from multiple myeloma. Leukemia Res. 1994;18:675-682.
9. Ishikawa H, Tsuyama N, Obata M, and Kawano MM. Mitogenic signals initiated via inteleukin-6 receptor complexes in corporation with other transmembrane molecules in myelomas. J Clin Exp Hematopathol. 2006;46:55-66.
10. Kudo O, Sabokbar A, Pocock A, Itonaga I, Fujikawa Y and Athanasou NA. Inteleukin-6 and IL-11 support human osteoclast formation by RANKL-independent mechanism. Bone. 2003;32:1-7.
11. Makhluf HA, Mueller SM., Mizuno S, Glowacki J. Age-related decline in osteoprotegerin expression by human bone marrow cells cultured in three-dimensional collagen sponges. Biochem Biophys Res Commun. 2000;268:669-672.
12. Mizuguchi H, Mizuno H, Yasukawa K, Ishiguro T, Fukui K, Imanaka T, Takagi M. Enhanced signal transduction by a directly fused protein of IL-6 and its receptor. J Biosci Bioeng. 2001;91:299-304.
13. Mueller SM, Glowacki J. Age-related decline in the osteogenic potential of human bone marrow cells cultured in tree-dimensional collagen sponges. J Cell Biochem. 2001;82: 583-590.
14. Ono A, Kanno H, Hayashi A, Nishimura S, Kuyama Y, Sato H, Ito S, Shimizu N, Chang CC, Yamamaoto I, Sasaki T, Tanaka M. Collagen gel matrix assay as an in vitro chemosensitivity test for malignant astrocytic tumors. Int J Clin Oncol. 2007;12:125-130.
15. Oswald J, Steudel C, Salchert K, Joergensen B, Thide C, Ehninger G, Warner C, Bornhauser M. Gene-expressing profiling of CD34+ hematopoietic cells expanded in a collagen I matrix. Stem Cells. 2006; 24:494-500.
16. Paganelli C, Fontana P, Porta F, Majorana A, Pazzaglia UE, Sapelli PL. Indication on suitable scaffold as carrier of stem cells in the alveoloplasty of cleft palate. J Oral Rehabil. 2006; 33:625-629.
17. Stewart K, Monk P, Walsh S, Jefferiss CM, Letchford J, Beresford JN. STRO-1, HOP-26 (CD63), CD49a and SB-10 (CD166) as markers of primitive human marrow stromal cells and their more differentiated progeny: a comparative investigation in vitro. Cell Tissue Res. 2003;313:281-290.
18. Tjin EPM., Derksen PWB., Kataoka H, Spaargaren M, and Pals SY. Multiple myeloma cells catalyze hepatocyte growth factor (HGF) activation by secreting the serine protease HGF-activator. Blood. 2004;104:2172-2175.
19. Vincent T, Jourdan M, Sy MS, Klein B, and Mechti N. Hyaluronic acid induces survival and proliferation of human myeloma cells through an interleukin-6-mediated pathway involving the phosphorylation of retinoblastoma protein. J Biol Chem. 2001;276:14728-14736.
20. Wallace SR, Oken MM, Lunetta KL, Panoskaltsis-Mortari A and Masellis AM. Abnormalities of bone marrow mesenchymal cells in multiple myeloma patients. Cancer. 2001;1:1219-1230.
21. Zdzisińska B, Bojarska-Junak A, Dmoszyńska A, Kandefer-Szerszeń M. Abnormal cytokine production by bone marrow stromal cells of multiple myeloma patients in response to RPMI8226 cells. Arch Immunol Ther Exp. 2008;56:1-15.